265 related articles for article (PubMed ID: 22220265)
1. Pathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia.
Falanga A; Russo L; Tartari CJ
Mediterr J Hematol Infect Dis; 2011; 3(1):e2011068. PubMed ID: 22220265
[TBL] [Abstract][Full Text] [Related]
2. Advances in the management of coagulopathy in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
4. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
Tallman MS; Hakimian D; Kwaan HC; Rickles FR
Leuk Lymphoma; 1993 Sep; 11(1-2):27-36. PubMed ID: 8220153
[TBL] [Abstract][Full Text] [Related]
5. Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β.
Dunoyer-Geindre S; Rivier-Cordey AS; Tsopra O; Lecompte T; Kruithof EKO
Ann Hematol; 2017 Jun; 96(6):905-917. PubMed ID: 28343272
[TBL] [Abstract][Full Text] [Related]
6. [Acute promyelocytic leukemia: state-of-the-art management].
Asou N
Rinsho Ketsueki; 2018; 59(6):725-734. PubMed ID: 29973452
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells.
Dubois C; Schlageter MH; de Gentile A; Guidez F; Balitrand N; Toubert ME; Krawice I; Fenaux P; Castaigne S; Najean Y
Blood; 1994 Jun; 83(11):3264-70. PubMed ID: 8193361
[TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide.
Shepshelovich D; Oniashvili N; Parnes D; Klein A; Muchtar E; Yeshaya J; Aviram A; Rabizadeh E; Raanani P
Cancer Genet; 2015 Nov; 208(11):575-9. PubMed ID: 26471811
[TBL] [Abstract][Full Text] [Related]
9. Acute Promyelocytic Leukemia: A History over 60 Years-From the Most Malignant to the most Curable Form of Acute Leukemia.
Thomas X
Oncol Ther; 2019 Jun; 7(1):33-65. PubMed ID: 32700196
[TBL] [Abstract][Full Text] [Related]
10. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
Falanga A; Rickles FR
Best Pract Res Clin Haematol; 2003 Sep; 16(3):463-82. PubMed ID: 12935963
[TBL] [Abstract][Full Text] [Related]
12. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
Chen SJ; Chen LJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
[TBL] [Abstract][Full Text] [Related]
13. The unique hemostatic dysfunction in acute promyelocytic leukemia.
Kwaan HC
Semin Thromb Hemost; 2014 Apr; 40(3):332-6. PubMed ID: 24590422
[TBL] [Abstract][Full Text] [Related]
14. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
15. Role of arsenic trioxide in acute promyelocytic leukemia.
Iland HJ; Seymour JF
Curr Treat Options Oncol; 2013 Jun; 14(2):170-84. PubMed ID: 23322117
[TBL] [Abstract][Full Text] [Related]
16. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J
Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia. New methods in diagnosis and treatment.
Varghese L; Janckila A; Yam LT
J Ky Med Assoc; 1999 Feb; 97(2):61-5. PubMed ID: 10073058
[TBL] [Abstract][Full Text] [Related]
18. Disseminated intravascular coagulation in acute leukemia.
Barbui T; Falanga A
Semin Thromb Hemost; 2001 Dec; 27(6):593-604. PubMed ID: 11740683
[TBL] [Abstract][Full Text] [Related]
19. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.
Dubois C; Schlageter MH; de Gentile A; Balitrand N; Toubert ME; Krawice I; Fenaux P; Castaigne S; Najean Y; Degos L
Leukemia; 1994 Oct; 8(10):1750-7. PubMed ID: 7523800
[TBL] [Abstract][Full Text] [Related]
20. Acute promyelocytic leukemia: recent advances in diagnosis and management.
Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]